Empirical antibiotic therapy for acute cystitis in children

For information on management of UTI in neonates and children younger than 3°months, see Urinary tract infection in neonates and children younger than 3 months.

Consider the child’s ability to swallow tablets or capsules and the availability and palatability of a formulation suitable for the child’s age (eg commercially available oral liquid formulation) when selecting an appropriate oral antibiotic. See Approach to empirical antibiotic choice for UTI in children for principles of antibiotic choice.

For empirical therapy for acute cystitis in children 3°months or older who can swallow tablets or capsules, while awaiting the results of culture and susceptibility testing, use:

1nitrofurantoin orally, 6-hourly for 5 days1 nitrofurantoin

child 29 kg to 50 kg: 50 mg

child more than 50 kg: 100 mg

OR

2trimethoprim orally, for 3 days2 3 trimethoprim

child 38 kg to 50 kg: 150 mg 12-hourly

child more than 50 kg: 300 mg once daily.

For empirical therapy for acute cystitis in children 3°months or older who cannot swallow tablets or capsules, while awaiting the results of culture and susceptibility testing, useNational Institute for Health and Care Excellence (NICE), October 2018Stein, 2015:

1cefalexin 12.5 mg/kg up to 500 mg orally, 6-hourly for 3 days cefalexin

OR if adherence to a 6-hourly regimen is unlikely

1cefalexin 20 mg/kg up to 750 mg orally, 8-hourly for 3 days4 cefalexin

OR

2trimethoprim+sulfamethoxazole (child 1 month or older) 4+20 mg/kg up to 160+800 mg orally, 12-hourly for 3 days2trimethoprim + sulfamethoxazole

OR (if a suitable trimethoprim formulation is available)

2trimethoprim 4 mg/kg up to 150 mg orally, 12-hourly for 3 days23.trimethoprim

If culture and susceptibility testing indicate the pathogen is resistant to empirical therapy, do not modify therapy if symptoms of cystitis are improving.

If the pathogen is resistant to empirical therapy and symptoms of cystitis are not improving, use the narrowest spectrum antibiotic to which the pathogen is susceptible.

For children with ongoing cystitis symptoms following appropriate antibiotic therapy, seek expert advice.

Do not perform post-treatment urine culture to confirm resolution of infection for asymptomatic children.

1 An oral liquid formulation of nitrofurantoin is not commercially available; for formulation options for children or people with swallowing difficulties, see Don’t Rush to Crush, which is available for purchase from the Advanced Pharmacy Australia website or through a subscription to eMIMSplus.Return
2 If the child has been treated with trimethoprim or trimethoprim+sulfamethoxazole in the previous 6 months, or had a trimethoprim-resistant (or trimethoprim+sulfamethoxazole-resistant) Escherichia coli isolate during this time, use an alternative antibiotic for empirical therapyBryce, 2016.Return
3 An oral liquid formulation of trimethoprim is not commercially available; for formulation options for children or people with swallowing difficulties, see Don’t Rush to Crush, which is available for purchase from the Advanced Pharmacy Australia website or through a subscription to eMIMSplus.Return
4 Unpublished pharmacokinetic and pharmacodynamic modelling data for cefalexin show similar levels of target attainment with the 6- and 8-hourly regimens above. It is the consensus view of the Antibiotic Expert Group that either regimen can be used for children.Return